Boehringer Ingelheim

Contact
boehringer-ingelheim.ca
+1905-639-0333

Boehringer Ingelheim (Canada) Ltd./Ltée

5180 South Service Road
L7L 5H4 Burlington
Canada
+1905-639-0333
boehringer-ingelheim.ca
Contact
Profile Products News
Contact

About Boehringer Ingelheim

We are constantly seeking new and better ways to treat people and animals. In the space of just two years, we have introduced several new products and have a number of new compounds in the pipeline. We have participated in joint ventures with other top multinational pharmaceutical companies - ventures that have improved quality of life for many thousands of Canadians and have perhaps saved the lives of thousands more. Our Vetmedica Division is an accomplished leader in veterinary medicine, offering innovative solutions in biologicals and specialty pharmaceuticals for beef and dairy cattle, swine, companion animals and horses.

Read more about Boehringer Ingelheim
Facts about Boehringer Ingelheim
  • Focus : Manufacturer
  • Employees: 10,001+
  • Industry : Pharma

Product portfolio of Boehringer Ingelheim

Product portfolio

Show all

News about Boehringer Ingelheim

Boehringer Ingelheim

06-Jun-2024 | business & finance

QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments

QUANTRO Therapeutics, a Spin-out from the research institutes IMBA and IMP in Vienna, announced that the company has reached a key milestone in its joint R ...

Read news
Boehringer Ingelheim

28-Nov-2023 | business & finance

German pharma company acquires University of Basel start-up for 450 million Swiss francs

New technology uses living bacteria to fight cancer

Read news
Boehringer Ingelheim

26-Apr-2023 | research and development

Boehringer Ingelheim inaugurates largest European development centre for biotechnology

Investment of 350 million euros is Boehringer Ingelheim's largest single investment in Germany to date

Read news
Boehringer Ingelheim

07-Jul-2022 | business & finance

Three partners committed to combat AMR

Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance

Read news
Boehringer Ingelheim

29-Nov-2021 | business & finance

PRIME’s technology for the development of novel veterinary vaccines

Boehringer Ingelheim and Biotech Startup enter a strategic collaboration

Read news
Boehringer Ingelheim

02-Nov-2021 | manufacturing

Boehringer Ingelheim opens smart factory

High-tech tablet production facility will further speed the market launch of innovative drugs

Read news
Boehringer Ingelheim

21-Oct-2021 | research and development

Boehringer Ingelheim and Partners to Accelerate Development of First-In-Class Gene Therapy for Patients with Cystic Fibrosis

Boehringer Ingelheim, IP Group, the UK Cystic Fibrosis Gene Therapy Consortium (GTC, consisting of researchers from Imperial College London and the ...

Read news
Boehringer Ingelheim

12-Jan-2021 | business & finance

Boehringer Ingelheim and Google Partner for Pharma R&D

Scientists from both companies will be breaking new ground in the application of quantum computing to molecular dynamics simulations

Read news
Show more news about Boehringer Ingelheim

Here you will find Boehringer Ingelheim (Canada) Ltd./Ltée